Age at implantation (years) | Mean | 58 +/- 14 | |
Range | 16–80 | ||
Gender | Men | 71% | 44 |
Women | 29% | 18 | |
Underlying cardiac disease | Coronary artery disease (CAD) | 62% | 40 |
Dilated cardiomyopathy | 11% | 7 | |
VT/VF without any known cardiac illness | 11% | 7 | |
Long QT-syndrome | 10% | 6 | |
Hypertrophic cardiomyopathy | 2% | 1 | |
Suspected drug related ventricular arrhythmia | 2% | 1 | |
Coronary artery spasm resulting in VT | 2% | 1 | |
Cardiac amyloidosis | 2% | 1 | |
Indication for implantation | Cardiac arrest due to VT or VF* | 52% | 32 |
VT without loss of consciousness | 42% | 26 | |
Syncope, VT/VF induced at EPS* | 6% | 4 | |
EF prior to implantation* | <20% | 3% | 2 |
21–40% | 37% | 22 | |
41–60% | 20% | 12 | |
>60% | 40% | 24 |